{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:56:04Z","timestamp":1792115764292,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.taap.2018.01.021","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T15:22:57Z","timestamp":1517412177000},"page":"79-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Atorvastatin and insulin equally mitigate brain pathology in diabetic rats"],"prefix":"10.1016","volume":"342","author":[{"given":"Wasana","family":"Pratchayasakul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La-ongdao","family":"Thongnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Chattipakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusorn","family":"Lungaphin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchalee","family":"Pongchaidecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattarapong","family":"Satjaritanun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thidarat","family":"Jaiwongkam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasiwan","family":"Kerdphoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriporn C.","family":"Chattipakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2018.01.021_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/cd16-0067","article-title":"Standards of medical care in diabetes-2017 abridged for primary care providers","volume":"35","author":"American Diabetes, A","year":"2017","journal-title":"Clin. Diabetes"},{"key":"10.1016\/j.taap.2018.01.021_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","article-title":"Insulin in the brain: there and back again","volume":"136","author":"Banks","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2018.01.021_bb0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnins.2015.00204","article-title":"Aberrant insulin signaling in Alzheimer's disease: current knowledge","volume":"9","author":"Bedse","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.taap.2018.01.021_bb0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fendo.2014.00161","article-title":"Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease","volume":"5","author":"Blazquez","year":"2014","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.taap.2018.01.021_bb0025","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/eurheartj\/ehr224","article-title":"Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1","volume":"33","author":"Bouitbir","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.taap.2018.01.021_bb0030","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.neuro.2008.04.012","article-title":"Very rapid quantification of malondialdehyde (MDA) in rat brain exposed to lead, aluminium and phenolic antioxidants by high-performance liquid chromatography-fluorescence detection","volume":"29","author":"Candan","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.taap.2018.01.021_bb0035","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1212\/01.wnl.0000344246.91081.2c","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early AD","volume":"72","author":"Dhamoon","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.taap.2018.01.021_bb0040","doi-asserted-by":"crossref","first-page":"384017","DOI":"10.1155\/2012\/384017","article-title":"Insulin in central nervous system: more than just a peripheral hormone","volume":"2012","author":"Duarte","year":"2012","journal-title":"J. Aging Res."},{"key":"10.1016\/j.taap.2018.01.021_bb0045","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.neubiorev.2013.03.010","article-title":"Effects of diabetes on hippocampal neurogenesis: links to cognition and depression","volume":"37","author":"Ho","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.taap.2018.01.021_bb0050","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","article-title":"Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer's disease: understanding the therapeutics strategies","volume":"53","author":"Kamat","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.taap.2018.01.021_bb0055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jns.2009.02.352","article-title":"Therapeutic potential of statins in Alzheimer's disease","volume":"283","author":"Kandiah","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.taap.2018.01.021_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10641960701813429","article-title":"Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats","volume":"30","author":"Kishi","year":"2008","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.taap.2018.01.021_bb0065","first-page":"373","article-title":"The relationship between Alzheimer's disease and diabetes: type 3 diabetes?","volume":"14","author":"Kroner","year":"2009","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.taap.2018.01.021_bb0070","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1074\/jbc.M310341200","article-title":"Characterization of superoxide-producing sites in isolated brain mitochondria","volume":"279","author":"Kudin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2018.01.021_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2012.06.050","article-title":"Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms","volume":"1471","author":"Kumar","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.taap.2018.01.021_bb0080","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S1734-1140(12)70930-1","article-title":"Protective effect of HMG CoA reductase inhibitors against running wheel activity induced fatigue, anxiety like behavior, oxidative stress and mitochondrial dysfunction in mice","volume":"64","author":"Kumar","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.taap.2018.01.021_bb0085","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/clc.20724","article-title":"Comparison of effects of simvastatin versus atorvastatin on oxidative stress in patients with coronary heart disease","volume":"33","author":"Li","year":"2010","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.taap.2018.01.021_bb0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12640-015-9527-y","article-title":"Atorvastatin prevents cognitive deficits induced by Intracerebroventricular amyloid-beta 1-40 Administration in Mice: involvement of glutamatergic and antioxidant systems","volume":"28","author":"Martins","year":"2015","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.taap.2018.01.021_bb0095","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.phrs.2008.07.005","article-title":"Therapeutic association of atorvastatin and insulin in cardiac ischemia: study in a model of type 2 diabetes with hyperlipidemia","volume":"58","author":"Matafome","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2018.01.021_bb0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00210-008-0363-y","article-title":"A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia","volume":"379","author":"Matafome","year":"2009","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.taap.2018.01.021_bb0105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ecl.2010.05.009","article-title":"Complications of type 1 diabetes","volume":"39","author":"Melendez-Ramirez","year":"2010","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.taap.2018.01.021_bb0110","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s11910-012-0297-0","article-title":"Insulin: an emerging treatment for Alzheimer's disease dementia?","volume":"12","author":"Morris","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.taap.2018.01.021_bb0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.metabol.2015.10.015","article-title":"Testosterone deprivation has neither additive nor synergistic effects with obesity on the cognitive impairment in orchiectomized and\/or obese male rats","volume":"65","author":"Pintana","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.taap.2018.01.021_bb0120","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/en.2011-1502","article-title":"PPARgamma agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets","volume":"153","author":"Pipatpiboon","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.taap.2018.01.021_bb0125","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.lfs.2011.02.003","article-title":"Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone","volume":"88","author":"Pratchayasakul","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2018.01.021_bb0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yhbeh.2015.04.023","article-title":"Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions","volume":"72","author":"Pratchayasakul","year":"2015","journal-title":"Horm. Behav."},{"key":"10.1016\/j.taap.2018.01.021_bb0135","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/GME.0000000000000838","article-title":"Estrogen and DPP-4 inhibitor share similar efficacy in reducing brain pathology caused by cardiac ischemia-reperfusion injury in both lean and obese estrogen-deprived rats","volume":"24","author":"Pratchayasakul","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.taap.2018.01.021_bb0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI77812","article-title":"The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2018.01.021_bb0145","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1139\/apnm-2015-0158","article-title":"Protocatechuic acid protects brain mitochondrial function in streptozotocin-induced diabetic rats","volume":"40","author":"Semaming","year":"2015","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"10.1016\/j.taap.2018.01.021_bb0150","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/archneurol.2011.242","article-title":"Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations","volume":"68","author":"Shepardson","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.taap.2018.01.021_bb0155","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0889-8529(05)70106-7","article-title":"Early diabetes-related complications in children and adolescents with type 1 diabetes. Implications for screening and intervention","volume":"28","author":"Sochett","year":"1999","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.taap.2018.01.021_bb0160","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.arcmed.2014.09.002","article-title":"DPP-4 inhibitor and PPARgamma agonist restore the loss of CA1 dendritic spines in obese insulin-resistant rats","volume":"45","author":"Sripetchwandee","year":"2014","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.taap.2018.01.021_bb0165","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","article-title":"Statins: mechanism of action and effects","volume":"5","author":"Stancu","year":"2001","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.taap.2018.01.021_bb0170","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00380-005-0833-9","article-title":"Effects of atorvastatin on inflammation and oxidative stress","volume":"20","author":"Sugiyama","year":"2005","journal-title":"Heart Vessel."},{"key":"10.1016\/j.taap.2018.01.021_bb0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5551\/jat.12.77","article-title":"Effects of atorvastatin on glucose metabolism and insulin resistance in KK\/Ay mice","volume":"12","author":"Suzuki","year":"2005","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.taap.2018.01.021_bb0180","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1177\/147323001103900440","article-title":"Beneficial effect of atorvastatin on renal function in patients with type 2 diabetes","volume":"39","author":"Tanaka","year":"2011","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.taap.2018.01.021_bb0185","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.mito.2011.01.008","article-title":"Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria","volume":"11","author":"Thummasorn","year":"2011","journal-title":"Mitochondrion"},{"key":"10.1016\/j.taap.2018.01.021_bb0190","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer's disease","volume":"57","author":"Tonnies","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.taap.2018.01.021_bb0195","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/1673-5374.128220","article-title":"Atorvastatin protects against cerebral ischemia\/reperfusion injury through anti-inflammatory and antioxidant effects","volume":"9","author":"Tu","year":"2014","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.taap.2018.01.021_bb0200","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.diabet.2009.04.004","article-title":"Lipid disorders in type 1 diabetes","volume":"35","author":"Verges","year":"2009","journal-title":"Diabete Metab."},{"key":"10.1016\/j.taap.2018.01.021_bb0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainres.2015.10.032","article-title":"Atorvastatin attenuates cognitive deficits through Akt1\/caspase-3 signaling pathway in ischemic stroke","volume":"1629","author":"Yang","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.taap.2018.01.021_bb0210","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/aps.2013.203","article-title":"Atorvastatin prevents amyloid-beta peptide oligomer-induced synaptotoxicity and memory dysfunction in rats through a p38 MAPK-dependent pathway","volume":"35","author":"Zhang","year":"2014","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18300280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18300280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T17:14:48Z","timestamp":1660410888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X18300280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":42,"alternative-id":["S0041008X18300280"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2018.01.021","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atorvastatin and insulin equally mitigate brain pathology in diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2018.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}